InvestSMART

Integral Diagnostics Limited (ASX: IDX) - Announcements

Current share price for IDX : $2.205 0.075 (3.29%)+

ASX company news and announcements for Integral Diagnostics Limited (IDX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Integral Diagnostics Limited (IDX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Integral Diagnostics Limited (IDX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Integral Diagnostics Limited (IDX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$823 2025 Annual General Meeting Date 2 Sep 2025 6:01PM $2.880 $2.205 fallen by 23.44%
$823 Change in Director's Interest Notice - Dr Ian Kadish 1 Sep 2025 5:15PM $2.890 $2.205 fallen by 23.70%
$823 Notification regarding unquoted securities - IDX 1 Sep 2025 5:15PM $2.890 $2.205 fallen by 23.70%
$823 Change in Director's Interest Notice - Dr Ian Kadish 29 Aug 2025 6:15PM $2.910 $2.205 fallen by 24.23%
$823 Notification regarding unquoted securities - IDX 29 Aug 2025 6:10PM $2.910 $2.205 fallen by 24.23%
$823 Application for quotation of securities - IDX 29 Aug 2025 6:05PM $2.910 $2.205 fallen by 24.23%
$823 Notification regarding unquoted securities - IDX 29 Aug 2025 5:52PM $2.910 $2.205 fallen by 24.23%
$823 Notification regarding unquoted securities - IDX 29 Aug 2025 8:11AM $2.940 $2.205 fallen by 25%
$823 Notification of cessation of securities - IDX 29 Aug 2025 8:11AM $2.940 $2.205 fallen by 25%
$823 Appendix 4G and Corporate Governance Statement 26 Aug 2025 9:35AM $2.720 $2.205 fallen by 18.93%
$823 Dividend/Distribution - IDX 26 Aug 2025 9:33AM $2.720 $2.205 fallen by 18.93%
$823 FY25 Investor Presentation 26 Aug 2025 9:29AM $2.720 $2.205 fallen by 18.93%
$823 FY25 Results Announcement 26 Aug 2025 9:25AM $2.720 $2.205 fallen by 18.93%
$823 Appendix 4E and FY25 Annual Report 26 Aug 2025 9:23AM $2.720 $2.205 fallen by 18.93%
$823 Release of Ordinary Shares from Escrow 22 Aug 2025 9:26AM $2.650 $2.205 fallen by 16.79%
$823 IDX FY25 Results Conference Call 23 Jul 2025 9:37AM $2.770 $2.205 fallen by 20.40%
$823 Commencement of litigation 23 Jul 2025 9:36AM $2.770 $2.205 fallen by 20.40%
$823 Ceasing to be a substantial holder 26 Jun 2025 8:22AM $2.410 $2.205 fallen by 8.51%
$823 Release of Ordinary Shares from Escrow 19 Jun 2025 6:05PM $2.260 $2.205 fallen by 2.43%
$823 Retirement of Managing Director and Chief Executive Officer 6 Jun 2025 4:12PM $2.320 $2.205 fallen by 4.96%
$823 Notification of cessation of securities - IDX 4 Jun 2025 6:10PM $2.390 $2.205 fallen by 7.74%
$823 Macquarie Conference Presentation 7 May 2025 9:28AM $2.360 $2.205 fallen by 6.57%
$823 Ceasing to be a substantial holder from CGF 5 May 2025 4:26PM $2.390 $2.205 fallen by 7.74%
$823 Change of Registered Office 17 Apr 2025 3:21PM $2.260 $2.205 fallen by 2.43%
$823 Notification of cessation of securities - IDX 9 Apr 2025 11:40AM $2.165 $2.205 risen by 1.85%

76 - 100 of 783 results

Page 4 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.